Hotline
+88 018777-71133
Investigation Support
+88 018445-22301
Medicine Support
+88 018445-22302
Open Hours
Hotline
Investigation Support
Medicine Support
Open Hours
Tab. Clavusef 125 mg + 31.25 mg is a medicine, menufectured by Opsonin Pharma Limited. It contains Cefuroxime+Clavulanic Acid
| SKU | PRO-12-0011470 |
|---|---|
| Dosage | Tab. |
| Brand Name | Clavusef |
| Generic | Cefuroxime+Clavulanic Acid |
| Strength | 125 mg + 31.25 mg |
| Manufacturer | Opsonin Pharma Limited |
| Pack | Piece | MRP | ARTO Price |
|---|---|---|---|
| Single | 1 | 18.05 BDT | 18.05 BDT |
| Box | 16 pcs | 288.80 BDT | 288.8 BDT |
| Cartoon | X | X | X |
Before taking Tab. Clavusef 125 mg + 31.25 mg, inform your doctor if you or your child have liver or kidney problems or any allergies. It should be used with caution in patients with liver problems due to alcohol to prevent the risk of liver damage.
Tab. Clavusef 125 mg + 31.25 mg should be used with caution in pregnant women only if clearly advised by the doctor and can be used in breastfeeding women.
Tab. Clavusef 125 mg + 31.25 mg is not recommended for use in children less than 10 years of age and should be used with caution in elderly patients.
Consult your doctor if you experience any side effects or unusual effects during treatment with Tab. Clavusef 125 mg + 31.25 mg.
It is unsafe to consume alcohol with Tab. Clavusef 125 mg + 31.25 mg
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.
